NORDIC NANOVECTOR TO PRESENT AT DNB HEALTHCARE CONFERENCE
Oslo, Norway, 12 December 2016 Nordic Nanovector ASA (OSE: NANO), a biotechnology company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces that its Chief Executive Officer, Luigi Costa, will present an overview of the company at the DNB Healthcare Conference in Oslo on Thursday December 15, 2016.The presentation will include an overview of Betalutin® data recently presented at ASH as well as Nordic Nanovector’s development strategy, key milestones and market opportunities. Mr. Costa will also provide a summary of